Examine the Feasibility of a Standardized Field Test for Marijuana Impairment: Laboratory Evaluations

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

December 1, 2017

Primary Completion Date

March 30, 2020

Study Completion Date

March 30, 2020

Conditions
Marijuana Impairment
Interventions
DRUG

Low Dose THC Marijuana

Dosing via vaporized marijuana using a lower concentration of THC, participants receive this dose on two of the five study visits.

DRUG

High Dose THC Marijuana

Dosing via vaporized marijuana using a higher concentration of THC, participants receive this dose on two of the five study visits.

DRUG

Placebo Marijuana

Dosing via vaporized marijuana with no THC, participants receive this dose on one of the five study visits.

Trial Locations (1)

06106

Olin Neuropsychiatry Research Center, Hartford

All Listed Sponsors
collaborator

National Highway Traffic Safety Administration (NHTSA)

FED

collaborator

Hartford Hospital

OTHER

collaborator

Montana State University

OTHER

collaborator

Maastricht University

OTHER

collaborator

The Mind Research Network

OTHER

collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Yale University

OTHER

NCT03191084 - Examine the Feasibility of a Standardized Field Test for Marijuana Impairment: Laboratory Evaluations | Biotech Hunter | Biotech Hunter